Systematic review with meta-analysis: vasoactive drugs for the treatment of hepatorenal syndrome type 1. (2017)
Attributed to:
Diagnosing chronic liver disease in primary care: developing a cost effective care pathway
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/apt.13912
PubMed Identifier: 28052382
Publication URI: http://europepmc.org/abstract/MED/28052382
Type: Journal Article/Review
Volume: 45
Parent Publication: Alimentary pharmacology & therapeutics
Issue: 5
ISSN: 0269-2813